Regulation of the phenotypic stability of chondrocytes by transmembrane heparan sulfate proteoglycans of the syndecan family
多聚糖家族跨膜硫酸乙酰肝素蛋白聚糖对软骨细胞表型稳定性的调节
基本信息
- 批准号:222638836
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:德国
- 项目类别:Independent Junior Research Groups
- 财政年份:2013
- 资助国家:德国
- 起止时间:2012-12-31 至 2018-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Transmembrane heparan sulfate proteoglycans of the syndecan family have been proposed to bind a large variety of proteins and thereby mediate an array different functions in cells. Sdc-4 is of major importance during stress situtations like fracture healing, wound healing and in osteoarthritis (OA). In my prelimiary studies I have shown that Sdc-4 can be compensated by Sdc-2 during development, but not during diseases like OA and fracture healing. Furthermore, I have shown that Sdc-4 is involved in WNT signal transduction, which is important in both processes of embryogenesis and OA. Based on my preliminary data I therefore hypothezise that Sdc-2 and -4 play a vital role in regulating chondrocyte phenotype and differentiation. In my project, I want to focus on the mechanisms of WNT induced signal transduction via syndecans, particularly Sdc-2 and-4. Furthermore, I want to use in both in vitro analyses with isolated chondrocytes and in vivo studies using wild type and syndecan- deficient animals to investigate the role of WNT signalling pathways in regulating the phenotypic stability of chondrocytes and their function in OA.. The results of this grant will lead to a better understanding of pathogenic mechanisms of OA and help to pave the path to new therapeutic approaches for this disease.
已经提出多配体蛋白聚糖家族的跨膜硫酸乙酰肝素蛋白聚糖结合多种蛋白质,从而介导细胞中的一系列不同功能。Sdc-4在骨折愈合、伤口愈合和骨关节炎(OA)等应激情况下非常重要。在我的前期研究中,我已经表明,Sdc-4可以在发育过程中被Sdc-2补偿,但在OA和骨折愈合等疾病中不能。此外,我已经表明,Sdc-4参与WNT信号转导,这是重要的胚胎发育和OA的过程。基于我的初步数据,我因此假设Sdc-2和-4在调节软骨细胞表型和分化中起着至关重要的作用。在我的项目中,我想专注于WNT通过syndecans诱导的信号转导机制,特别是Sdc-2和-4。此外,我想在使用分离的软骨细胞的体外分析和使用野生型和syndecan缺陷动物的体内研究中使用,以研究WNT信号传导途径在调节软骨细胞的表型稳定性及其在OA中的功能中的作用。这项资助的结果将有助于更好地了解OA的致病机制,并有助于为这种疾病的新治疗方法铺平道路。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Antibody-mediated inhibition of syndecan-4 dimerisation reduces interleukin (IL)-1 receptor trafficking and signalling
- DOI:10.1136/annrheumdis-2019-216847
- 发表时间:2020-04-01
- 期刊:
- 影响因子:27.4
- 作者:Godmann, Lars;Bollmann, Miriam;Bertrand, Jessica
- 通讯作者:Bertrand, Jessica
BCP crystals promote chondrocyte hypertrophic differentiation in OA cartilage by sequestering Wnt3a
- DOI:10.1136/annrheumdis-2019-216648
- 发表时间:2020-07-01
- 期刊:
- 影响因子:27.4
- 作者:Bertrand, Jessica;Kraft, Tabea;Pap, Thomas
- 通讯作者:Pap, Thomas
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Professorin Dr. Jessica Bertrand其他文献
Professorin Dr. Jessica Bertrand的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Professorin Dr. Jessica Bertrand', 18)}}的其他基金
Role of BCP crystals in regulating the chondrocytic phenotype in osteoarthritis
BCP晶体在调节骨关节炎软骨细胞表型中的作用
- 批准号:
430270172 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Research Grants
Involvement of syndecan-4 in wnt signalling in cartilage biologie
syndecan-4 参与软骨生物学中的 WNT 信号传导
- 批准号:
185242740 - 财政年份:2010
- 资助金额:
-- - 项目类别:
Research Fellowships
Antibacterial modification of the marginal layer by silver-integrated ED-Machining of TiAl6V4-implant material – AbakSi
通过 TiAl6V4 植入材料的银集成 ED 加工对边缘层进行抗菌改性 – AbakSi
- 批准号:
456414530 - 财政年份:
- 资助金额:
-- - 项目类别:
Research Grants
相似海外基金
Integrative analysis of whole genomes and transcriptomes from multiple cell types in rare disease patients
罕见病患者多种细胞类型的全基因组和转录组的综合分析
- 批准号:
10587683 - 财政年份:2023
- 资助金额:
-- - 项目类别:
The Epitranscriptome as a Novel Mechanism of Arsenic-Induced Diabetes.
表观转录组作为砷诱发糖尿病的新机制。
- 批准号:
10518402 - 财政年份:2021
- 资助金额:
-- - 项目类别:
The Epitranscriptome as a Novel Mechanism of Arsenic-Induced Diabetes.
表观转录组作为砷诱发糖尿病的新机制。
- 批准号:
10322037 - 财政年份:2021
- 资助金额:
-- - 项目类别:
PheWAS and GWAS of Telomere Length to Understand Human Disease
利用端粒长度的 PheWAS 和 GWAS 了解人类疾病
- 批准号:
10458116 - 财政年份:2020
- 资助金额:
-- - 项目类别:
PheWAS and GWAS of Telomere Length to Understand Human Disease
利用端粒长度的 PheWAS 和 GWAS 了解人类疾病
- 批准号:
10664860 - 财政年份:2020
- 资助金额:
-- - 项目类别:
DNA Repair Phenotype the Missing Link in Breast Cancer Risk Assessment
DNA 修复表型是乳腺癌风险评估中缺失的一环
- 批准号:
10267896 - 财政年份:2020
- 资助金额:
-- - 项目类别:
PheWAS and GWAS of Telomere Length to Understand Human Disease
利用端粒长度的 PheWAS 和 GWAS 了解人类疾病
- 批准号:
10264785 - 财政年份:2020
- 资助金额:
-- - 项目类别:
PheWAS and GWAS of Telomere Length to Understand Human Disease
利用端粒长度的 PheWAS 和 GWAS 了解人类疾病
- 批准号:
9886470 - 财政年份:2020
- 资助金额:
-- - 项目类别:
DNA Repair Phenotype the Missing Link in Breast Cancer Risk Assessment
DNA 修复表型是乳腺癌风险评估中缺失的一环
- 批准号:
10656666 - 财政年份:2018
- 资助金额:
-- - 项目类别: